Mesalazine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mesalazine
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Zhejiang Hengkang Mesalazine

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Mesalazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

92 API Suppliers, 53 USDMF, 35 CEP/COS, 13 JDMF, 14 EU WC, 10 KDMF, 45 NDC API, 42 Listed Suppliers, $ API Reference Price

92 API Suppliers
53 USDMF
35 CEP/COS
13 JDMF
14 EU WC
10 KDMF
45 NDC API
42 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

446 FDF Dossiers, 41 FDA Orange Book, 293 Europe, 18 Canada, 40 Australia, 12 South Africa, 42 Listed Dossiers

446 FDF Dossiers
41 FDA Orange Book
293 Europe
18 Canada
40 Australia
12 South Africa
42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

ENEMA;RECTAL - 4GM/60ML, CAPSULE, EXTENDED RELEASE;ORAL - 250MG, CAPSULE, EXTENDED RELEASE;ORAL - 500MG, CAPSULE, DELAYED RELEASE;ORAL - 400MG, SUPPOSITORY;RECTAL - 1GM, TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 1.2GM, CAPSULE, EXTENDED RELEASE;ORAL - 375MG

ENEMA;RECTAL - 4GM/60ML
CAPSULE, EXTENDED RELEASE;ORAL - 250MG
CAPSULE, EXTENDED RELEASE;ORAL - 500MG
CAPSULE, DELAYED RELEASE;ORAL - 400MG
SUPPOSITORY;RECTAL - 1GM
TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - 1.2GM
CAPSULE, EXTENDED RELEASE;ORAL - 375MG

RELATED EXCIPIENT COMPANIES

8 Evonik, 3 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 11 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 15 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 9 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 30 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 17 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 13 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 55 Fillers, Diluents & Binders, 43 Controlled & Modified Release, 36 Thickeners and Stabilizers, 28 Solubilizers, 27 Disintegrants & Superdisintegrants, 22 Granulation, 22 Direct Compression, 17 Lubricants & Glidants, 15 Topical, 15 Film Formers & Plasticizers, 11 Taste Masking, 9 Empty Capsules, 8 Rheology Modifiers, 8 Co-Processed Excipients, 7 Chewable & Orodispersible Aids, 6 Parenteral, 5 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 1 Surfactant & Foaming Agents

69 Coating Systems & Additives
55 Fillers, Diluents & Binders
43 Controlled & Modified Release
36 Thickeners and Stabilizers
28 Solubilizers
27 Disintegrants & Superdisintegrants
22 Granulation
22 Direct Compression
17 Lubricants & Glidants
15 Topical
15 Film Formers & Plasticizers
11 Taste Masking
9 Empty Capsules
8 Rheology Modifiers
8 Co-Processed Excipients
7 Chewable & Orodispersible Aids
6 Parenteral
5 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 67 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
67 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 200 Finished Drug Prices, 35 Annual Reports

9 US Medicaid Prescriptions
200 Finished Drug Prices
35 Annual Reports

MARKET PLACE

22 APIs, 14 FDF Dossiers

22 APIs
14 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 13 Health Canada Patents

4 US Patents
13 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 15 Others

4 EDQM
1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 47 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 2ABBVIE

02 1MYLAN SPECIALITY LP

03 1SALIX

filter Patent Number Reset all filters

4 All

01 17645801

02 18217083

03 18436051

04 18865688

filter API Patent Reset all filters

4 All

01 1Y

02 3Blank

filter FDF Patent Reset all filters

4 All

01 3Y

02 1Blank

filter Expiration Date Reset all filters

4 All

01 12027-07-24

02 22028-06-06

03 12030-05-01

Axplora Mesalazine

Product Main Page

01

ABBVIE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-06

US Patent Number : 8217083

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21252

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-06

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-06

US Patent Number : 8436051

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21252

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-06

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

03

SALIX

BioAsia

Not Confirmed

SALIX

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-05-01

US Patent Number : 8865688

Drug Substance Claim :

Drug Product Claim :

Application Number : 22301

Patent Use Code : U-1310

Delist Requested :

Patent Use Description : FOR THE MAINTENANCE OF...

Patent Expiration Date : 2030-05-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MYLAN SPECIALITY LP

BioAsia

Not Confirmed

MYLAN SPECIALITY LP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-24

US Patent Number : 7645801

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 19618

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!